The EU’s new Health Technology Assessment (HTA) Regulation marks a turning point in delivering cutting-edge healthcare to patients across Europe. By harmonizing assessments for medicines and medical devices, it speeds up decisions on pricing and reimbursement, reduces duplication of work, and involves patients and clinicians in the evaluation process. Ultimately, this coordinated approach means faster, […]
Tag: Patients
Pharmaceutical companies are on a war footing as the Commission proposes to shorten the duration of patents for some medicines so that new companies can enter the pharmaceutical market, to address the growing shortage of medicines, insufficient research on new antimicrobial and to lower selling prices of pharmaceutical products. In addition, the Commission justifies the […]

